| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Prazosin measurement (procedure) |
Component |
True |
Prazosin (substance) |
Inferred relationship |
Some |
1 |
| Prazosin adverse reaction |
Causative agent (attribute) |
True |
Prazosin (substance) |
Inferred relationship |
Some |
1 |
| Allergy to prazosin |
Causative agent (attribute) |
False |
Prazosin (substance) |
Inferred relationship |
Some |
|
| Furazosin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prazosin (substance) |
Inferred relationship |
Some |
|
| Prazosin hydrochloride (substance) |
Is a |
False |
Prazosin (substance) |
Inferred relationship |
Some |
|
| Product containing prazosin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prazosin (substance) |
Inferred relationship |
Some |
1 |
| Allergy to prazosin |
Causative agent (attribute) |
True |
Prazosin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely prazosin (as prazosin hydrochloride) 500 microgram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Prazosin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely prazosin (as prazosin hydrochloride) 1 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Prazosin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely prazosin (as prazosin hydrochloride) 2 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Prazosin (substance) |
Inferred relationship |
Some |
1 |
| Prazosin (as prazosin hydrochloride) 5 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Prazosin (substance) |
Inferred relationship |
Some |
1 |
| Prazosin hydrochloride (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Prazosin (substance) |
Inferred relationship |
Some |
|
| Prazosin-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prazosin (substance) |
Inferred relationship |
Some |
1 |
| Product containing only prazosin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prazosin (substance) |
Inferred relationship |
Some |
1 |
| Product containing only prazosin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prazosin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely polythiazide 500 microgram and prazosin (as prazosin hydrochloride) 5 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Prazosin (substance) |
Inferred relationship |
Some |
1 |
| Polythiazide 500 microgram and prazosin (as prazosin hydrochloride) 1 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Prazosin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely polythiazide 500 microgram and prazosin (as prazosin hydrochloride) 2 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Prazosin (substance) |
Inferred relationship |
Some |
1 |
| Product containing polythiazide and prazosin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prazosin (substance) |
Inferred relationship |
Some |
1 |
| Polythiazide and prazosin only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prazosin (substance) |
Inferred relationship |
Some |
1 |
| Product containing polythiazide and prazosin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prazosin (substance) |
Inferred relationship |
Some |
1 |
| Product containing only polythiazide and prazosin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Prazosin (substance) |
Inferred relationship |
Some |
1 |
| Prazosin (as prazosin hydrochloride) 5 mg prolonged-release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Prazosin (substance) |
Inferred relationship |
Some |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]